Eosinophilic Granulomatosis with Polyangiitis
📧 Sign up to get email alerts when something new happens for Eosinophilic Granulomatosis with Polyangiitis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2024-03-12Clinical Trial Update: Long-term Access Program (LAP) of Mepolizumab for Subjects Who Participated in Study MEA115921 [Phase 3]
Phase 3 long-term access program update for mepolizumab in subjects from a prior study; results completed and posted.
-
CLINICAL_TRIALS trial_result · 2021-03-08Clinical Trial Update: Benralizumab in the Treatment of Eosinophilic Granulomatosis With Polyangiitis (EGPA) Study [Phase 2]
Phase 2 trial evaluating benralizumab for eosinophilic granulomatosis with polyangiitis (EGPA) in patients with asthma; current status is un…
-
FDA approval · 2020-09-25FDA Approved: NUCALA — Supplemental Application (GlaxoSmithKline LLC)
FDA approves a supplemental application for NUCALA (mepolizumab) submitted by GlaxoSmithKline LLC.
-
FDA approval · 2019-10-03FDA Approved: FASENRA — Supplemental Application (AstraZeneca Pharmaceuticals LP)
FDA approved a supplemental application for FASENRA (benralizumab) from AstraZeneca, updating its labeling and/or indications.
-
FDA approval · 2019-09-12FDA Approved: NUCALA — Supplemental Application (GlaxoSmithKline LLC)
The FDA approved a supplemental application for NUCALA (mepolizumab) submitted by GlaxoSmithKline LLC.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2018-06-06Clinical Trial Update: Journey of Patients With Vasculitis From First Symptom to Diagnosis
A completed University of Pennsylvania clinical study tracks vasculitis patients from first symptoms through diagnosis, describing the diagn…
-
CLINICAL_TRIALS trial_result · 2018-01-26Clinical Trial Update: A Study to Investigate Mepolizumab in the Treatment of Eosinophilic Granulomatosis With Polyangiitis [Phase 3]
A Phase 3 trial evaluating mepolizumab for eosinophilic granulomatosis with polyangiitis (Churg-Strauss syndrome) has completed; results wer…
-
CLINICAL_TRIALS trial_result · 2017-09-14Clinical Trial Update: Reslizumab in the Treatment of Eosinophilic Granulomatosis With Polyangiitis (EGPA) Study [Phase 2]
Phase 2 clinical trial update for reslizumab in eosinophilic granulomatosis with polyangiitis (EGPA) related asthma.
-
CLINICAL_TRIALS trial_result · 2017-08-01Clinical Trial Update: Immuno-ablation With Chemoimmunoradiation and Autologous Stem Cell Transplant for Churg-Strauss Syndrome [EARLY_Phase 1]
A Phase 1 trial evaluating immuno-ablation with chemoimmunoradiation and autologous stem cell transplant for eosinophilic granulomatosis wit…
-
CLINICAL_TRIALS trial_result · 2017-05-04Clinical Trial Update: The ANCA Vasculitis Questionnaire (AAV-PRO©)
The ANCA Vasculitis Questionnaire (AAV-PRO©) trial update notes that the study evaluating a patient-reported outcome instrument for ANCA-ass…
-
CLINICAL_TRIALS trial_result · 2017-03-22Clinical Trial Update: Mepolizumab As a Steroid-sparing Treatment Option in the Churg Strauss Syndrome [Phase 1, Phase 2]
Mepolizumab is being studied as a steroid-sparing treatment option for eosinophilic granulomatosis with polyangiitis (Churg-Strauss syndrome…
-
CLINICAL_TRIALS research · 2016-08-19Clinical Trial Update: American College of Rheumatology/European League Against Rheumatism (ACR/EULAR) Diagnostic and Classification Criteria for Primary Systemic Vasculitis
This clinical trial update describes progress on the ACR/EULAR diagnostic and classification criteria for primary systemic vasculitis, spons…
-
CLINICAL_TRIALS research · 2016-01-28Clinical Trial Update: Impact of Vasculitis on Employment and Income
This completed clinical trial update examines how vasculitis and its subtypes impact employment and income for patients.
-
CLINICAL_TRIALS research · 2015-05-28Clinical Trial Update: PRO Development for ANCA Associated Vasculitis
Clinical trial update describing the development of a patient-reported outcome measure for ANCA-associated vasculitis.
-
CLINICAL_TRIALS research · 2014-07-15Clinical Trial Update: Educational Needs of Patients With Systemic Vasculitis
The document reports on a completed clinical trial evaluating the educational needs and resources for patients with systemic vasculitis.
-
CLINICAL_TRIALS trial_result · 2014-07-15Clinical Trial Update: Vasculitis Illness Perception (VIP) Study
The Vasculitis Illness Perception (VIP) study has completed. The update lists several vasculitis conditions studied, including granulomatosi…
-
CLINICAL_TRIALS trial_result · 2014-06-26Clinical Trial Update: Reproductive Health in Men and Women With Vasculitis
A completed clinical trial evaluating reproductive health in men and women with various forms of vasculitis.
-
CLINICAL_TRIALS research · 2014-04-29Clinical Trial Update: Observation Study of Clinical Manifestation and Outcome in Chinese Patients With Pulmonary Vasculitis
An observational study update on pulmonary vasculitis in Chinese patients, describing clinical manifestations and outcomes across ANCA-assoc…
-
CLINICAL_TRIALS trial_result · 2011-12-08Clinical Trial Update: Rituxan in Churg Strauss Syndrome With Renal Involvement [Phase 2]
A Phase 2 trial of rituximab for eosinophilic granulomatosis with polyangiitis (Churg-Strauss syndrome) with renal involvement was terminate…
-
CLINICAL_TRIALS trial_result · 2011-09-12Clinical Trial Update: Treatment of Necrotizing Vasculitides for Patients Older Than 65 Years [Phase 4]
A Phase 4 clinical trial update from Assistance Publique - Hôpitaux de Paris evaluating treatment for necrotizing vasculitides in patients a…
-
CLINICAL_TRIALS research · 2008-09-12Clinical Trial Update: Cyclophosphamide Versus Methotrexate for Remission Maintenance in Systemic Necrotizing Vasculitides [Phase 2]
Phase 2 trial comparing cyclophosphamide versus methotrexate for remission maintenance in systemic necrotizing vasculitides. The current tri…
-
CLINICAL_TRIALS trial_result · 2007-11-19Clinical Trial Update: RATTRAP: Infliximab Versus Rituximab in Systemic Necrotizing Vasculitides [NA]
This completed trial compared infliximab versus rituximab in systemic necrotizing vasculitides, including granulomatosis with polyangiitis, …
-
CLINICAL_TRIALS research · 2006-11-14Clinical Trial Update: CHUSPAN SCS BP Treatment of Churg-Strauss Syndrome Without Poor-Prognosis Factors [Phase 4]
Phase 4 clinical trial update for CHUSPAN SCS BP in eosinophilic granulomatosis with polyangiitis (Churg-Strauss syndrome); current trial st…